" class="no-js "lang="en-US"> Johnson & Johnson Archives - Medtech Alert
Sunday, June 16, 2024

Sort by:


Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Johnson & Johnson Appoints Dr. John Reed as Executive Vice President, Pharmaceuticals, R&D

Johnson & Johnson has announced the appointment of John Reed, to the Company’s Executive Committee as […]

Immunyx Pharma Selected to Join BLUE KNIGHT

Immunyx Pharma, a developer of immune modulating therapies for neutrophil-based diseases, announced it has been […]

Johnson & Johnson Appoints Thibaut Mongon as CEO Designate of Planned New Consumer Health Company

Johnson & Johnson (the “Company”) (NYSE: JNJ) today announced the appointment of Thibaut Mongon as […]

Janssen Discontinues Collaboration and License Agreements with Bavarian Nordic in Hepatitis B and Human Papillomavirus

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the termination of its collaboration […]

Johnson & Johnson Names Darius Adamczyk, Chairman and Chief Executive Officer of Honeywell, to its Board of Directors

Johnson & Johnson (NYSE: JNJ) announced today that Darius Adamczyk, Chairman and Chief Executive Officer of Honeywell, […]

Johnson & Johnson COVID-19 Vaccine Fully Approved by Health Canada to Prevent COVID-19 in Individuals 18 years and Older

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that Health Canada has approved […]

Johnson & Johnson COVID-19 Vaccine Booster Shot Authorized for Emergency Use by U.S. FDA

Johnson & Johnson (NYSE: JNJ) (the Company) today announced the U.S. Food and Drug Administration (FDA) […]

DePuy Synthes Introduces the INHANCE ™ Shoulder System, a First-to-Market, Fully Integrated Shoulder Arthroplasty System

Today, The Johnson & Johnson Medical Devices Companies announced that DePuy Synthes, The Orthopaedics Company […]

Ethicon's Echelon Circular Powered Stapler Associated with Major Reduction in Serious Complications Following Colorectal Surgery

Ethicon, part of the Johnson & Johnson Medical Devices Companies, today announced the results of […]

MedTech Innovator Selects 20 Premier Startups for Annual Asia Pacific Accelerator

MedTech Innovator, the largest accelerator of medical device companies in the world, in partnership with Asia […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more